$FPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIVE PRIME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in FIVE PRIME THERAPEUTICS, INC.. Get notifications about new insider transactions in FIVE PRIME THERAPEUTICS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Sell | S | 34.75 | 6,600 | 229,350 | 89,319 | 95.9 K to 89.3 K (-6.88 %) |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | M | 7.26 | 10,000 | 72,600 | 95,919 | 85.9 K to 95.9 K (+11.64 %) |
| Oct 30 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | P | 13.70 | 64 | 877 | 64 | 0 to 64 |
| Oct 30 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | P | 10.75 | 400 | 4,300 | 1,700 | 1.3 K to 1.7 K (+30.77 %) |
| Oct 30 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | P | 10.10 | 500 | 5,050 | 1,300 | 800 to 1.3 K (+62.50 %) |
| Oct 30 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | P | 14.75 | 800 | 11,800 | 800 | 0 to 800 |
| Oct 26 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Gift | G | 0.00 | 3,337 | 0 | 291,256 | 294.6 K to 291.3 K (-1.13 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 27.98 | 4,904 | 137,214 | 294,593 | 299.5 K to 294.6 K (-1.64 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 27.36 | 20,096 | 549,827 | 299,497 | 319.6 K to 299.5 K (-6.29 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 26.68 | 25,000 | 667,000 | 319,593 | 344.6 K to 319.6 K (-7.25 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 27.58 | 22,352 | 616,468 | 344,593 | 366.9 K to 344.6 K (-6.09 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 27.00 | 25,000 | 675,000 | 2,539,949 | 2.6 M to 2.5 M (-0.97 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 28.85 | 25,000 | 721,250 | 2,564,949 | 2.6 M to 2.6 M (-0.97 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 27.58 | 65,687 | 1,811,647 | 2,589,949 | 2.7 M to 2.6 M (-2.47 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 28.02 | 9,313 | 260,950 | 2,655,636 | 2.7 M to 2.7 M (-0.35 %) |
| Sep 29 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | EVP & Chief Busines ... | Option Exercise | M | 5.54 | 2,000 | 11,080 | 25,812 | |
| Sep 29 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | EVP & Chief Busines ... | Option Exercise | M | 8.49 | 708 | 6,011 | 5,582 | |
| Sep 29 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | EVP & Chief Busines ... | Buy | M | 5.54 | 2,000 | 11,080 | 182,673 | 180.7 K to 182.7 K (+1.11 %) |
| Sep 29 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | EVP & Chief Busines ... | Buy | M | 8.49 | 708 | 6,011 | 180,673 | 180 K to 180.7 K (+0.39 %) |
| Sep 24 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 12.70 | 12,500 | 158,750 | 0 | |
| Sep 24 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 12.70 | 12,500 | 158,750 | 73,890 | 61.4 K to 73.9 K (+20.36 %) |
| Sep 23 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 22.06 | 2,648 | 58,422 | 366,945 | 369.6 K to 366.9 K (-0.72 %) |
| Sep 04 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 7.26 | 4,065 | 29,512 | 0 | |
| Sep 04 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 8.49 | 4,065 | 34,512 | 0 | |
| Sep 04 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 7.26 | 4,065 | 29,512 | 61,390 | 57.3 K to 61.4 K (+7.09 %) |
| Sep 04 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 8.49 | 4,065 | 34,512 | 57,325 | 53.3 K to 57.3 K (+7.63 %) |
| Aug 21 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Grant | A | 0.00 | 75,000 | 0 | 369,593 | 294.6 K to 369.6 K (+25.46 %) |
| Aug 21 2015 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Grant | A | 0.00 | 75,000 | 0 | 83,570 | 8.6 K to 83.6 K (+875.15 %) |
| Aug 21 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | EVP & Chief Busines ... | Grant | A | 0.00 | 75,000 | 0 | 179,965 | 105 K to 180 K (+71.45 %) |
| Aug 21 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Grant | A | 0.00 | 75,000 | 0 | 85,740 | 10.7 K to 85.7 K (+698.32 %) |
| Aug 21 2015 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | SVP and CFO | Grant | A | 0.00 | 75,000 | 0 | 80,680 | 5.7 K to 80.7 K (+1,320.42 %) |
| Aug 19 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Option Exercise | A | 19.25 | 125,000 | 2,406,250 | 125,000 | |
| Aug 19 2015 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | SVP, Gen Counsel & ... | Option Exercise | A | 19.25 | 75,000 | 1,443,750 | 75,000 | |
| Aug 19 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | A | 19.25 | 75,000 | 1,443,750 | 75,000 | |
| Aug 19 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | SVP & Chief Medical ... | Option Exercise | A | 19.25 | 75,000 | 1,443,750 | 75,000 | |
| Aug 19 2015 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | SVP and CFO | Option Exercise | A | 19.25 | 45,000 | 866,250 | 45,000 | |
| Aug 13 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 5.54 | 3,000 | 16,620 | 27,812 | |
| Aug 13 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 5.54 | 3,000 | 16,620 | 103,389 | 100.4 K to 103.4 K (+2.99 %) |
| Jul 31 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 5.54 | 15,804 | 87,554 | 30,812 | |
| Jul 31 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 8.49 | 354 | 3,005 | 6,290 | |
| Jul 31 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 8.49 | 339 | 2,878 | 0 | |
| Jul 31 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 5.54 | 15,804 | 87,554 | 100,389 | 84.6 K to 100.4 K (+18.68 %) |
| Jul 31 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 8.49 | 354 | 3,005 | 84,585 | 84.2 K to 84.6 K (+0.42 %) |
| Jul 31 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 8.49 | 339 | 2,878 | 84,231 | 83.9 K to 84.2 K (+0.40 %) |
| Jul 02 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 6.89 | 2,439 | 16,805 | 0 | |
| Jul 02 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 5.54 | 4,065 | 22,520 | 0 | |
| Jul 02 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 6.89 | 2,439 | 16,805 | 53,260 | 50.8 K to 53.3 K (+4.80 %) |
| Jul 02 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 5.54 | 4,065 | 22,520 | 50,821 | 46.8 K to 50.8 K (+8.69 %) |
| Jun 26 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 6.89 | 1,788 | 12,319 | 0 | |
| Jun 26 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 11.14 | 6,471 | 72,087 | 43,529 | |
| Jun 26 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 8.49 | 10,347 | 87,846 | 6,644 | |
| Jun 26 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 8.49 | 15,921 | 135,169 | 339 | |
| Jun 26 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 5.54 | 3,557 | 19,706 | 46,616 | |
| Jun 26 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 6.89 | 1,788 | 12,319 | 83,892 | 82.1 K to 83.9 K (+2.18 %) |
| Jun 26 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 11.14 | 6,471 | 72,087 | 82,104 | 75.6 K to 82.1 K (+8.56 %) |
| Jun 26 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 8.49 | 10,347 | 87,846 | 75,633 | 65.3 K to 75.6 K (+15.85 %) |
| Jun 26 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 8.49 | 15,921 | 135,169 | 65,286 | 49.4 K to 65.3 K (+32.25 %) |
| Jun 26 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 5.54 | 3,557 | 19,706 | 49,365 | 45.8 K to 49.4 K (+7.77 %) |
| Jun 24 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 24.77 | 60,822 | 1,506,804 | 294,593 | 355.4 K to 294.6 K (-17.11 %) |
| Jun 24 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 24.23 | 14,178 | 343,575 | 355,415 | 369.6 K to 355.4 K (-3.84 %) |
| Jun 19 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | M | 6.89 | 9,756 | 67,219 | 0 | |
| Jun 19 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | M | 6.89 | 9,756 | 67,219 | 46,756 | 37 K to 46.8 K (+26.37 %) |
| Jun 16 2015 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | A | 22.15 | 12,500 | 276,875 | 12,500 | |
| Jun 16 2015 | FPRX | FIVE PRIME THERAPE ... | MCDADE MARK | Director | Option Exercise | A | 22.15 | 12,500 | 276,875 | 12,500 | |
| Jun 16 2015 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | A | 22.15 | 12,500 | 276,875 | 12,500 | |
| Jun 16 2015 | FPRX | FIVE PRIME THERAPE ... | Douglas R Lee | Director | Option Exercise | A | 22.15 | 12,500 | 276,875 | 12,500 | |
| Jun 16 2015 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | A | 22.15 | 12,500 | 276,875 | 12,500 | |
| Jun 16 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | A | 22.15 | 12,500 | 276,875 | 12,500 | |
| Jun 16 2015 | FPRX | FIVE PRIME THERAPE ... | ATWOOD BRIAN G | Director | Option Exercise | A | 22.15 | 12,500 | 276,875 | 12,500 | |
| May 04 2015 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | SVP and CFO | Grant | A | 0.00 | 5,680 | 0 | 5,680 | 0 to 5.7 K |
| May 04 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Grant | A | 0.00 | 13,090 | 0 | 369,593 | 356.5 K to 369.6 K (+3.67 %) |
| May 04 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Grant | A | 0.00 | 7,480 | 0 | 45,808 | 38.3 K to 45.8 K (+19.52 %) |
| May 04 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | SVP & Chief Medical ... | Grant | A | 0.00 | 7,980 | 0 | 9,979 | 2 K to 10 K (+399.20 %) |
| May 04 2015 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | SVP, Gen Counsel & ... | Grant | A | 0.00 | 6,110 | 0 | 8,570 | 2.5 K to 8.6 K (+248.37 %) |
| Apr 14 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 5.54 | 3,557 | 19,706 | 50,173 | |
| Apr 14 2015 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 5.54 | 3,557 | 19,706 | 38,328 | 34.8 K to 38.3 K (+10.23 %) |
| Jan 29 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 27.03 | 25,000 | 675,750 | 37,000 | 12 K to 37 K (+208.33 %) |
| Jan 16 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 25.76 | 5,049 | 130,065 | 12,000 | 7 K to 12 K (+72.64 %) |
| Jan 16 2015 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 26.58 | 5,000 | 132,888 | 6,951 | 2 K to 7 K (+256.28 %) |
| Dec 12 2014 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 5.54 | 3,180 | 17,617 | 53,730 | |
| Dec 12 2014 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 6.89 | 10,000 | 68,900 | 1,788 | |
| Dec 12 2014 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | M | 4.56 | 1,186 | 5,408 | 0 | |
| Dec 12 2014 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 5.54 | 3,180 | 17,617 | 34,771 | 31.6 K to 34.8 K (+10.07 %) |
| Dec 12 2014 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 6.89 | 10,000 | 68,900 | 31,591 | 21.6 K to 31.6 K (+46.32 %) |
| Dec 12 2014 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Buy | M | 4.56 | 1,186 | 5,408 | 21,591 | 20.4 K to 21.6 K (+5.81 %) |
| Dec 02 2014 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 21.04 | 1,100 | 23,144 | 1,951 | 851 to 2 K (+129.26 %) |
| Dec 02 2014 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 21.04 | 851 | 17,901 | 851 | 0 to 851 |
| Nov 04 2014 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 13.11 | 7,143 | 93,650 | 356,503 | 363.6 K to 356.5 K (-1.96 %) |
| Nov 04 2014 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 13.05 | 13,559 | 177,007 | 363,646 | 377.2 K to 363.6 K (-3.59 %) |
| Nov 04 2014 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 13.09 | 11,901 | 155,752 | 377,205 | 389.1 K to 377.2 K (-3.06 %) |
| Oct 30 2014 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 13.32 | 5,838 | 77,779 | 389,106 | 394.9 K to 389.1 K (-1.48 %) |
| Oct 30 2014 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 13.03 | 1,825 | 23,783 | 394,944 | 396.8 K to 394.9 K (-0.46 %) |
| Oct 30 2014 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 13.04 | 9,734 | 126,911 | 396,769 | 406.5 K to 396.8 K (-2.39 %) |
| Oct 02 2014 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | A | 11.65 | 25,000 | 291,250 | 25,000 | |
| Aug 26 2014 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Option Exercise | A | 11.14 | 125,000 | 1,392,500 | 125,000 | |
| Aug 26 2014 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | SVP, Gen Counsel & ... | Option Exercise | A | 11.14 | 35,000 | 389,900 | 35,000 | |
| Aug 26 2014 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | SVP & Chief Medical ... | Option Exercise | A | 11.14 | 50,000 | 557,000 | 50,000 | |
| Aug 26 2014 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | SVP & Chief Busines ... | Option Exercise | A | 11.14 | 50,000 | 557,000 | 50,000 | |
| Aug 26 2014 | FPRX | FIVE PRIME THERAPE ... | Kavanaugh William Michael | SVP & Chief Scienti ... | Option Exercise | A | 11.14 | 15,000 | 167,100 | 15,000 | |
| Aug 26 2014 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | SVP and CFO | Option Exercise | A | 11.14 | 30,000 | 334,200 | 30,000 | |
| Jul 03 2014 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | J | 0.00 | 57 | 0 | 112 | 55 to 112 (+103.64 %) |
| Jul 03 2014 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | J | 0.00 | 55 | 0 | 55 | 0 to 55 |
| May 21 2014 | FPRX | FIVE PRIME THERAPE ... | Douglas R Lee | Director | Option Exercise | A | 12.70 | 12,500 | 158,750 | 12,500 | |
| May 20 2014 | FPRX | FIVE PRIME THERAPE ... | MCDADE MARK | Director | Option Exercise | A | 12.70 | 12,500 | 158,750 | 12,500 | |
| May 20 2014 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | A | 12.70 | 12,500 | 158,750 | 12,500 | |
| May 20 2014 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | A | 12.70 | 12,500 | 158,750 | 12,500 | |
| May 20 2014 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | A | 12.70 | 12,500 | 158,750 | 12,500 | |
| May 20 2014 | FPRX | FIVE PRIME THERAPE ... | ATWOOD BRIAN G | Director | Option Exercise | A | 12.70 | 12,500 | 158,750 | 12,500 | |
| Nov 07 2013 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | SVP, Gen Counsel & ... | Option Exercise | A | 10.77 | 7,000 | 75,390 | 7,000 | |
| Sep 24 2013 | FPRX | FIVE PRIME THERAPE ... | Douglas R Lee | Director | Option Exercise | C | 0.00 | 119 | 0 | 0 | |
| Sep 24 2013 | FPRX | FIVE PRIME THERAPE ... | Douglas R Lee | Director | Option Exercise | C | 0.00 | 4,065 | 0 | 0 | |
| Sep 24 2013 | FPRX | FIVE PRIME THERAPE ... | Douglas R Lee | Director | Buy | C | 0.00 | 119 | 0 | 4,184 | 4.1 K to 4.2 K (+2.93 %) |
| Sep 24 2013 | FPRX | FIVE PRIME THERAPE ... | Douglas R Lee | Director | Buy | C | 0.00 | 4,065 | 0 | 4,065 | 0 to 4.1 K |
| Sep 24 2013 | FPRX | FIVE PRIME THERAPE ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 28,989 | 0 | 0 | |
| Sep 24 2013 | FPRX | FIVE PRIME THERAPE ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 986,240 | 0 | 0 | |
| Sep 24 2013 | FPRX | FIVE PRIME THERAPE ... | ATWOOD BRIAN G | Director | Buy | P | 13.00 | 76,923 | 999,999 | 1,092,152 | 1 M to 1.1 M (+7.58 %) |
| Sep 24 2013 | FPRX | FIVE PRIME THERAPE ... | ATWOOD BRIAN G | Director | Buy | C | 0.00 | 28,989 | 0 | 1,015,229 | 986.2 K to 1 M (+2.94 %) |
| Sep 24 2013 | FPRX | FIVE PRIME THERAPE ... | ATWOOD BRIAN G | Director | Buy | C | 0.00 | 986,240 | 0 | 986,240 | 0 to 986.2 K |